ATE237613T1 - Verfahren für die herstellung von antiviralen substituierten 1, 3-oxathiolanen - Google Patents
Verfahren für die herstellung von antiviralen substituierten 1, 3-oxathiolanenInfo
- Publication number
- ATE237613T1 ATE237613T1 AT93900063T AT93900063T ATE237613T1 AT E237613 T1 ATE237613 T1 AT E237613T1 AT 93900063 T AT93900063 T AT 93900063T AT 93900063 T AT93900063 T AT 93900063T AT E237613 T1 ATE237613 T1 AT E237613T1
- Authority
- AT
- Austria
- Prior art keywords
- oxathiolanes
- production
- antiviral
- substituted
- antiviral substituted
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/308,101 US5047407A (en) | 1989-02-08 | 1989-02-08 | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| US56416090A | 1990-08-07 | 1990-08-07 | |
| CA002152269A CA2152269C (en) | 1989-02-08 | 1992-12-21 | Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
| PCT/CA1992/000557 WO1994014802A1 (en) | 1989-02-08 | 1992-12-21 | Process for preparing substituted 1,3-oxathiolanes with antiviral properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE237613T1 true ATE237613T1 (de) | 2003-05-15 |
Family
ID=27170036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93900063T ATE237613T1 (de) | 1989-02-08 | 1992-12-21 | Verfahren für die herstellung von antiviralen substituierten 1, 3-oxathiolanen |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0674634B1 (de) |
| JP (1) | JP3160291B2 (de) |
| AT (1) | ATE237613T1 (de) |
| AU (1) | AU3154993A (de) |
| CA (1) | CA2152269C (de) |
| DE (1) | DE69233014T2 (de) |
| DK (1) | DK0674634T3 (de) |
| ES (1) | ES2196004T3 (de) |
| HU (1) | HU226137B1 (de) |
| PT (1) | PT674634E (de) |
| WO (1) | WO1994014802A1 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6175008B1 (en) * | 1988-04-11 | 2001-01-16 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
| US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
| US5827727A (en) * | 1990-02-01 | 1998-10-27 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
| US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| US5914331A (en) * | 1990-02-01 | 1999-06-22 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
| GB9116601D0 (en) * | 1991-08-01 | 1991-09-18 | Iaf Biochem Int | 1,3-oxathiolane nucleoside analogues |
| US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
| WO1995007086A1 (en) * | 1993-09-10 | 1995-03-16 | Emory University | Nucleosides with anti-hepatitis b virus activity |
| US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
| IL113432A (en) * | 1994-04-23 | 2000-11-21 | Glaxo Group Ltd | Process for the diastereoselective synthesis of nucleoside analogues |
| US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
| US5703058A (en) * | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
| US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
| DK0831852T3 (da) | 1995-06-07 | 2007-03-19 | Univ Emory | Nukleosider med anti-hepatitis B-virusaktivitet |
| US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
| IT1290447B1 (it) | 1997-03-28 | 1998-12-03 | Zambon Spa | Derivati 1,3-ossatiolanici ad attivita' antivirale |
| JP2001518899A (ja) | 1997-04-07 | 2001-10-16 | トライアングル ファーマシューティカルズ，インコーポレイティド | 他の抗ウイルス剤との組合せにおけるｍｋｃ−４４２の使用 |
| EA004767B1 (ru) | 1998-12-23 | 2004-08-26 | Шайре Байокем Инк. | Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция |
| US20030162992A1 (en) * | 2001-12-14 | 2003-08-28 | Watanabe Kyoichi A. | Preparation of intermediates useful in the synthesis of antiviral nucleosides |
| DE10238722A1 (de) | 2002-08-23 | 2004-03-11 | Bayer Ag | Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse |
| DE10238724A1 (de) | 2002-08-23 | 2004-03-04 | Bayer Ag | Alkyl-substituierte Pyrazolpyrimidine |
| SI2225232T1 (sl) | 2007-11-29 | 2012-12-31 | Ranbaxy Laboratories Limited | Postopek za pripravo substituiranih 1,3-oksatiolanov |
| EP2217602B1 (de) | 2007-11-30 | 2018-08-29 | Boehringer Ingelheim International GmbH | 1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-on- derivative und ihre verwendung als pde9a modulatoren zur behandlung von erkrankungen des zns |
| UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
| PE20110383A1 (es) | 2008-09-08 | 2011-07-15 | Boehringer Ingelheim Int | Pirazolopirimidinonas como inhibidores de la fosfodiesterasa 9a (pde9a) |
| CA2757231A1 (en) | 2009-03-31 | 2010-10-07 | Boehringer Ingelheim International Gmbh | 1-heterocyclyl-1,5-dihydro-pyrazolo [3,4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
| CA2807687C (en) | 2010-08-12 | 2019-01-08 | Boehringer Ingelheim International Gmbh | 6-cycloalkyl-1, 5-dihydro-pyrazolo [3,4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors |
| US8809345B2 (en) | 2011-02-15 | 2014-08-19 | Boehringer Ingelheim International Gmbh | 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders |
| CN104059057A (zh) * | 2014-01-03 | 2014-09-24 | 石家庄龙泽制药有限公司 | 拉米夫定杂质3-tu的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
| US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
| GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
| JP2960164B2 (ja) * | 1990-11-13 | 1999-10-06 | バイオケム ファーマ インコーポレイテッド | 抗ウイルス特性を有する置換１，３−オキサチオラン類および置換１，３−ジチオラン類 |
| WO1992010496A1 (en) * | 1990-12-05 | 1992-06-25 | University Of Georgia Research Foundation, Inc. | ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES |
| IL100965A (en) * | 1991-02-22 | 1999-12-31 | Univ Emory | 2-Hydroxymethyl-5-(5-fluorocytosin-l-yl)-1,3-oxathiolane its resolution and pharmaceutical compositions containing it |
| RU2116789C1 (ru) * | 1991-03-06 | 1998-08-10 | Дзе Велкам Фаундейшн Лимитед | Способ ингибирования вирусных инфекций гепатита в |
| WO1992018517A1 (en) * | 1991-04-17 | 1992-10-29 | Yale University | Method of treating or preventing hepatitis b virus |
| ZA923640B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
-
1992
- 1992-12-21 HU HU9501825A patent/HU226137B1/hu not_active IP Right Cessation
- 1992-12-21 WO PCT/CA1992/000557 patent/WO1994014802A1/en not_active Ceased
- 1992-12-21 CA CA002152269A patent/CA2152269C/en not_active Expired - Fee Related
- 1992-12-21 EP EP93900063A patent/EP0674634B1/de not_active Expired - Lifetime
- 1992-12-21 AT AT93900063T patent/ATE237613T1/de not_active IP Right Cessation
- 1992-12-21 DK DK93900063T patent/DK0674634T3/da active
- 1992-12-21 ES ES93900063T patent/ES2196004T3/es not_active Expired - Lifetime
- 1992-12-21 AU AU31549/93A patent/AU3154993A/en not_active Abandoned
- 1992-12-21 DE DE69233014T patent/DE69233014T2/de not_active Expired - Fee Related
- 1992-12-21 JP JP51462194A patent/JP3160291B2/ja not_active Expired - Fee Related
- 1992-12-21 PT PT93900063T patent/PT674634E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2196004T3 (es) | 2003-12-16 |
| DE69233014T2 (de) | 2004-01-08 |
| AU3154993A (en) | 1994-07-19 |
| HU226137B1 (en) | 2008-05-28 |
| WO1994014802A1 (en) | 1994-07-07 |
| DE69233014D1 (de) | 2003-05-22 |
| CA2152269A1 (en) | 1994-07-07 |
| PT674634E (pt) | 2003-09-30 |
| EP0674634B1 (de) | 2003-04-16 |
| JP3160291B2 (ja) | 2001-04-25 |
| DK0674634T3 (da) | 2003-08-04 |
| CA2152269C (en) | 1999-09-21 |
| EP0674634A1 (de) | 1995-10-04 |
| HUT73655A (en) | 1996-09-30 |
| HU9501825D0 (en) | 1995-08-28 |
| JPH08504212A (ja) | 1996-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE237613T1 (de) | Verfahren für die herstellung von antiviralen substituierten 1, 3-oxathiolanen | |
| ES2091948T3 (es) | 1,3-oxatiolanos sustituidos con propiedades antiviricas. | |
| ATE44954T1 (de) | Carbostyrilderivat und verfahren zu seiner herstellung. | |
| ATE136315T1 (de) | Verfahren für die herstellung von polyethylenglykolderivate und modifizierte proteine. | |
| AT380252B (de) | Verfahren zur herstellung von neuen guanin- und 2,6-diaminopurinderivaten und ihren salzen | |
| ATE139778T1 (de) | Xanthinverbindungen | |
| ATE158798T1 (de) | Verfahren zur herstellung von optisch aktiven zyklobutannukleosiden | |
| EP0382526A3 (de) | Substituierte 1,3-Oxathiolane mit antiviraler Wirkung | |
| DE69108014D1 (de) | Verfahren zur herstellung von nucleosiden und ihre analogen. | |
| ATE123777T1 (de) | Verfahren zur herstellung von (6s)- und (6r)- tetrahydrofolsäure. | |
| ATE57703T1 (de) | Verfahren zur herstellung von 2,6-substituierten 9-(1,3-dihydroxy-2-propoxymethyl)-purinen und einige derivate. | |
| ES545194A0 (es) | Un procedimiento para preparar derivados de purina | |
| ATE130845T1 (de) | Verfahren zur herstellung von 3-amino-2- (het)aroyl-acrylsäurederivaten. | |
| ATE116636T1 (de) | Verfahren zur herstellung von 2,6- dichlordiphenylaminessigsäurederivaten. | |
| FI890678A0 (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi | |
| IT8548429A0 (it) | Composizione a base di esteri parziali dell'acido fosforico,impiegabili per l'ingrasso in mezzo acquoso delle pelli conciate | |
| ATE132863T1 (de) | Verfahren zur herstellung von 6-(substituiertes aminopropionyl)-derivaten von forskolin | |
| ATE147075T1 (de) | Purinverbindungen, verfahren zu ihrer herstellung, pharmazeutische präparate und zwischenverbindungen | |
| DE68904680D1 (de) | Carbamatderivate und verfahren zu ihrer herstellung. | |
| DE3667464D1 (de) | Verfahren zur herstellung von 2-acyl-3,4-dialkoxyanilinen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0674634 Country of ref document: EP |
|
| EEFA | Change of the company name | ||
| EEFA | Change of the company name | ||
| REN | Ceased due to non-payment of the annual fee |